Santen Pharmaceutical Co Ltd (4536.T)
4536.T on Tokyo Stock Exchange
1,859JPY
16 Nov 2018
1,859JPY
16 Nov 2018
Change (% chg)
¥31 (+1.70%)
¥31 (+1.70%)
Prev Close
¥1,828
¥1,828
Open
¥1,838
¥1,838
Day's High
¥1,871
¥1,871
Day's Low
¥1,829
¥1,829
Volume
938,800
938,800
Avg. Vol
1,274,112
1,274,112
52-wk High
¥2,061
¥2,061
52-wk Low
¥1,608
¥1,608
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Sep | 57,861.00 | 18.437 |
| Jun | 56,483.00 | 16.794 | |
| FY 2018 | Mar '18 | 56,350.00 | 19.396 |
| Dec | 57,817.00 | 29.598 | |
| Sep | 54,826.00 | 15.300 | |
| Jun | 55,949.00 | 22.122 | |
| FY 2017 | Mar '17 | 48,429.00 | 11.201 |
| Dec | 52,838.00 | 11.399 | |
| Sep | 47,823.00 | 12.478 | |
| Jun | 50,006.00 | 17.613 | |
| FY 2016 | Mar '16 | 46,087.00 | 8.384 |
| Dec | 51,331.00 | 14.986 | |
| Sep | 49,898.00 | 86.897 | |
| Jun | 47,975.00 | 18.152 |
*Note: Units in Millions ofYen
**Note: Units in Yen
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 3 | 54,958.00 | 56,308.00 | 53,408.00 | -- |
| Quarter Ending Jun-19 | 1 | 59,400.00 | 59,400.00 | 59,400.00 | -- |
| Year Ending Mar-18 | 10 | 221,315.00 | 224,800.00 | 206,000.00 | -- |
| Year Ending Mar-19 | 10 | 237,178.00 | 239,400.00 | 235,200.00 | 227,302.00 |
| Year Ending Mar-20 | 10 | 250,762.00 | 259,517.00 | 245,000.00 | 241,038.00 |
| Earnings (per share) | |||||
| Quarter Ending Mar-18 | 2 | 10.86 | 10.96 | 10.77 | -- |
| Quarter Ending Jun-19 | 1 | 22.12 | 22.12 | 22.12 | -- |
| Year Ending Mar-18 | 11 | 76.62 | 80.42 | 68.62 | -- |
| Year Ending Mar-19 | 11 | 78.76 | 88.58 | 70.78 | 75.63 |
| Year Ending Mar-20 | 11 | 85.64 | 98.30 | 76.20 | 84.70 |
| LT Growth Rate (%) | 1 | 3.70 | 3.70 | 3.70 | 11.29 |
Sales and Profit Figures in Japanese Yen (JPY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 28.99 | 31.23 | 33.59 | |
| P/E High - Last 5 Yrs. | 30.21 | 40.67 | 45.05 | |
| P/E Low - Last 5 Yrs. | 13.18 | 24.06 | 24.37 | |
| Beta | 0.58 | 0.92 | 0.91 | |
| Price to Sales (TTM) | 3.46 | 4.01 | 5.69 | |
| Price to Book (MRQ) | 2.73 | 5.04 | 5.11 | |
| Price to Tangible Book (MRQ) | 4.49 | 5.77 | 6.54 | |
| Price to Cash Flow (TTM) | 20.38 | 23.28 | 23.52 | |
| % Owned Institutions | -- | 0.96 | 1.86 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 1.49 | 1.54 | 1.48 | |
| Dividend Yield - 5 Year Avg | 1.65 | 1.55 | 1.50 | |
| Dividend 5 Year Growth Rate | 5.39 | 4.20 | 5.08 | |
| Payout Ratio(TTM) | 43.17 | 45.75 | 43.86 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 11.88 | 2.38 | 7.42 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 3.91 | 4.87 | 5.86 | |
| Sales - 5 Yr. Growth Rate | 11.72 | 10.03 | 10.16 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 24.23 | 17.59 | 21.18 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -52.93 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 7.31 | 9.81 | 10.63 | |
| Capital Spending - 5 Yr. Growth Rate | 23.70 | 15.39 | 15.17 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.62 | 2.20 | 2.26 |
| Current Ratio (MRQ) | 3.16 | 3.02 | 3.09 |
| LT Debt to Equity (MRQ) | 2.37 | 8.92 | 11.53 |
| Total Debt to Equity (MRQ) | 8.05 | 12.75 | 15.71 |
| Interest Coverage (TTM) | 47.31 | 35.11 | 32.23 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 61.88 | 54.28 | 54.07 | |
| Gross Margin - 5 Yr. Avg. | 63.12 | 51.72 | 51.84 | |
| EBITD Margin (TTM) | 21.40 | -- | -- | |
| EBITD - 5 Yr. Avg | 28.55 | 18.38 | 11.80 | |
| Operating Margin (TTM) | 16.45 | 14.42 | 4.85 | |
| Operating Margin - 5 Yr. Avg. | 24.66 | 14.54 | 7.45 | |
| Pre-Tax Margin (TTM) | 16.47 | 14.94 | 5.82 | |
| Pre-Tax Margin - 5 Yr. Avg. | 24.72 | 14.96 | 7.86 | |
| Net Profit Margin (TTM) | 12.02 | 11.15 | 2.08 | |
| Net Profit Margin - 5 Yr. Avg. | 16.64 | 11.22 | 4.10 | |
| Effective Tax Rate (TTM) | 27.04 | 23.47 | 23.39 | |
| Effective Tax Rate - 5 Yr. Avg. | 32.70 | 23.63 | 24.13 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 55,914,640 | 1,003,835,279 | 905,691,028 | |
| Net Income/Employee (TTM) | 6,721,026 | 119,027,147 | 107,333,733 | |
| Receivable Turnover (TTM) | 2.81 | 5.83 | 5.95 | |
| Inventory Turnover (TTM) | 2.98 | 2.68 | 3.63 | |
| Asset Turnover (TTM) | 0.63 | 1.00 | 0.97 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 7.53 | 12.00 | 11.52 | |
| Return on Assets - 5 Yr. Avg. | 10.07 | 13.31 | 12.71 | |
| Return on Investment (TTM) | 8.89 | 15.57 | 15.05 | |
| Return on Investment - 5 Yr. Avg. | 12.19 | 17.33 | 16.50 | |
| Return on Equity (TTM) | 9.56 | 16.94 | 16.62 | |
| Return on Equity - 5 Yr. Avg. | 13.23 | 18.26 | 17.61 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 1.95 | 10.83 | 11.72 |
| EPS (TTM) % | -56.40 | 5.54 | 7.31 |
| Dividend % | 4.00 | 9.14 | 5.39 |
Note: Units in Millions of US Dollars
Performance for Santen Pharmaceutical Co Ltd
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -2.24 | -7.67 | 99 | 20 |
| 13 Week | 13.02 | 7.65 | 99 | 34 |
| 26 Week | 15.03 | 1.57 | 99 | 28 |
| 52 Week | 14.80 | -7.87 | 99 | 11 |
| YTD | 22.03 | 9.84 | 99 | 25 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 50.41% |
| # of Holders: | 251 |
| Total Shares Held: | 205,238,720 |
| 3 Mo. Net Change: | 19,303,051 |
| # New Positions: | 4 |
| # Closed Positions: | 6 |
| # Increased Positions: | 63 |
| # Reduced Positions: | 50 |
| # Net Buyers: | 13 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.